Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv in Childhood Intermittent Explosive Disorder
NCT02048241Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jul 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in intermittent explosive disorder (IED), sponsored by New York State Psychiatric Institute. Started Jul 2011; status: completed.
02
Drugs
guanfacine
03
Conditions
intermittent explosive disorder (IED)
Beyond the preview
Go deeper on NCT02048241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048241.